Literature DB >> 22333696

One-year follow-up of tick-borne central nervous system infections in childhood.

Mona-Lisa Engman1, Katarina Lindström, Marie Sallamba, Carl Hertz, Berit Sundberg, Magnus E A Hansson, Lars Lindquist, Claes Orvell, Karl-Johan Lidefelt, Mikael Sundin.   

Abstract

BACKGROUND: Neurologic sequelae, including cognitive deficits, after childhood tick-borne encephalitis (TBE) and neuroborreliosis (NB) are not well-characterized. These infections are among the most common affecting the central nervous system in children and can be difficult to diagnose due to vague symptomatology. The aim of this study was to investigate long-term (>1 year) consequences of pediatric TBE and NB as well as the value of markers for brain damage and genetic susceptibility.
METHODS: From a previous prospective study, children diagnosed with TBE (n = 8) and NB (n = 12) as well as pediatric controls (n = 15) were followed up by clinical examination, semistructured interview and screening for cognitive dysfunction by the Five-to-Fifteen Questionnaire. The follow-up also included detection of serum autoantibodies against the neural proteins; glial fibrillary acidic protein and myelin basic protein, as well as genotyping of a 32 basepair deletion in the chemokine receptor type 5 gene.
RESULTS: Children diagnosed with TBE displayed significantly more long-term subjective complaints (ie, fatigue, headache and irritability) compared with the NB and control groups. Significantly higher frequency of disabilities was also detected by the Five-to-Fifteen Questionnaire in the TBE group. Both TBE and NB cause consequences (eg, prolonged convalescence, worries and financial loss) for the families. Markers for genetic susceptibility and brain damage had no prognostic values in this cohort.
CONCLUSIONS: Pediatric TBE results in long-lasting residual symptoms and neurologic deficits affecting daily life. Vigilance for TBE-related morbidity among pediatricians and long-term clinical follow-up with assessment of cognitive dysfunctions and appropriate interventions seems reasonable for these children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333696     DOI: 10.1097/INF.0b013e31824f23c0

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

Review 1.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

2.  Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic).

Authors:  Lenka Krbková; Hana Štroblová; Jana Bednářová
Journal:  Eur J Pediatr       Date:  2014-09-10       Impact factor: 3.183

Review 3.  Tick-borne encephalitis in children.

Authors:  Kevin Rostasy
Journal:  Wien Med Wochenschr       Date:  2012-06-12

Review 4.  [Tick-borne encephalitis].

Authors:  R Kaiser
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

5.  Estimating the annual burden of tick-borne encephalitis to inform vaccination policy, Slovenia, 2009 to 2013.

Authors:  Mario Fafangel; Alessandro Cassini; Edoardo Colzani; Irena Klavs; Marta Grgič Vitek; Veronika Učakar; Marion Muehlen; Marko Vudrag; Alenka Kraigher
Journal:  Euro Surveill       Date:  2017-04-20

6.  The Kynurenine Pathway is Differentially Activated in Children with Lyme Disease and Tick-Borne Encephalitis.

Authors:  Ronny Wickström; Åsa Fowler; Michel Goiny; Vincent Millischer; Sofia Ygberg; Lilly Schwieler
Journal:  Microorganisms       Date:  2021-02-04

Review 7.  Sleep-Wake and Circadian Disorders after Tick-Borne Encephalitis.

Authors:  Gabriele Chiffi; Denis Grandgirard; Parham Sendi; Anelia Dietmann; Claudio L A Bassetti; Stephen L Leib
Journal:  Microorganisms       Date:  2022-01-27

8.  The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden.

Authors:  Daniel Slunge
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

Review 9.  Proposed Lyme Disease Guidelines and Psychiatric Illnesses.

Authors:  Robert C Bransfield; Michael J Cook; Douglas R Bransfield
Journal:  Healthcare (Basel)       Date:  2019-09-09

Review 10.  Neurocognitive impacts of arbovirus infections.

Authors:  Marion Clé; Patrick Eldin; Laurence Briant; Annie Lannuzel; Yannick Simonin; Philippe Van de Perre; André Cabié; Sara Salinas
Journal:  J Neuroinflammation       Date:  2020-08-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.